Media Area

Working together to help transform the diagnosis, management and treatment of disease forever. 

Press & Media


The Clinithink team enjoys collaborating  with journalists and media outlets around the world to share compelling, unique stories about AI and the role it plays in solving some of the most complex challenges in healthcare today.

If you are a member of the media and you would like to talk to us, please email our Communications Team at:


About Clinithink:

Clinithink is a UK based technology company that has developed the world’s first Healthcare AI capable of truly understanding unstructured medical notes.

Its CLiX® intelligence platform delivers the deepest, fastest and most accurate analysis of unstructured data across patient populations currently possible.

Whether it’s to better understand a vulnerable population, to highlight important phenotypes or to reduce the risk of denied claims for providers, Clinithink’s solutions provide healthcare decision-makers with better information and insight. Through automation, these insights can be gained in a fraction of the time of that manual processing would require and at reduced cost. 

For more information about Clinithink, please visit our About Us page.


Latest news at Clinithink:

  • To view the latest news and press releases about Clinithink, please visit our News section.
  • For more background into the key topics within the healthcare AI space, please explore our Blog section.
  • Clinithink is proud to have won a number of industry awards, in recognition for its hard work and dedication in the healthcare and technology space. For more information, visit our Awards section.


Other information:

  • For more insights about our AI technology, please visit our Technology page
  • To learn more about our leadership team, please visit the Leadership page
  • More information about Clinithink's patented CLiX® technology, the application of healthcare AI and its importance to healthcare delivery, check out our FAQs section


Should you require any further information or insights, please contact the Communications Team on: